ProlyteORS, Cipla Health Limited’s flagship oral rehydration solution, has welcomed the recent directive from the Food Safety and Standards Authority of India (FSSAI), which requires that the term ‘ORS’ can only appear on products that meet the medically approved WHO formulation. The move aligns regulatory standards with scientific accuracy, ensuring consumers can identify genuine, effective rehydration solutions. ProlyteORS is formulated to deliver the precise balance of electrolytes, glucose, and sodium recommended by WHO, and Cipla Health emphasizes that its brand remains the #TrueORS, reflecting transparency, integrity, and evidence-based formulation.
Shivam Puri, MD & CEO of Cipla Health Limited, said, “FSSAI’s directive is a positive step in reinforcing consumer trust and public health by ensuring clarity in ORS labelling. ProlyteORS has always met the highest standards of scientific formulation and quality. The #TrueORS promise represents our unwavering commitment to safety, effectiveness, and transparent communication, helping consumers make informed choices.”
Cipla Health Limited is a wholly owned subsidiary of Cipla Limited, one of India’s leading pharmaceutical companies. Established to extend Cipla’s legacy of care beyond prescription medicines, Cipla Health focuses on consumer healthcare and wellness solutions that empower individuals to take charge of their health. The company offers a diverse portfolio across categories such as nutrition, immunity, cough and cold, oral care, women’s health, and pain management, among others.
Its popular brands include Cofsils (for sore throat and cough relief), Prolyte (oral rehydration salts), Nicotex (a nicotine replacement therapy aiding smoking cessation), Maxirich (vitamin and supplement range), and Clocip (antifungal treatments). These products are trusted by millions of consumers in India and several international markets for their quality, safety, and efficacy.
Cipla Health combines the scientific expertise of its parent company with modern marketing and digital outreach, making healthcare solutions more accessible, affordable, and consumer-friendly. With a mission to promote “Caring for Life”, the company aims to bridge the gap between pharmaceuticals and everyday wellness by addressing preventive and lifestyle health needs. Through continuous innovation and a strong distribution network, Cipla Health Limited continues to shape the future of India’s fast-growing consumer healthcare segment.
